Warren Center for Neuroscience Drug Discovery researchers create new compound to potentially treat negative and positive symptoms of schizophrenia

Researchers at Vanderbilt University's Warren Center for Neuroscience Drug Discovery, led by Craig Lindsley, have developed a novel compound targeting both positive and negative symptoms of schizophrenia. While current treatments address positive symptoms like delusions and hallucinations, they often neglect negative symptoms such as social withdrawal and lack of emotional expression. This new compound aims to improve cognitive functions and overall quality of life for patients by addressing these unmet needs.

Read more on this article here.